Meredith C. Henderson

780 total citations
14 papers, 489 citations indexed

About

Meredith C. Henderson is a scholar working on Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Meredith C. Henderson has authored 14 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Meredith C. Henderson's work include Radiomics and Machine Learning in Medical Imaging (3 papers), AI in cancer detection (3 papers) and RNA Interference and Gene Delivery (3 papers). Meredith C. Henderson is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (3 papers), AI in cancer detection (3 papers) and RNA Interference and Gene Delivery (3 papers). Meredith C. Henderson collaborates with scholars based in United States, Czechia and Canada. Meredith C. Henderson's co-authors include David O. Azorsa, Daniel D. Von Hoff, Shilpi Arora, Spyro Mousses, Ashish Choudhary, Jeffrey M. Trent, Laurence H. Hurley, Haiyong Han, Robert T. Dorr and Gary A. Flynn and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Meredith C. Henderson

13 papers receiving 480 citations

Peers

Countries citing papers authored by Meredith C. Henderson

Since Specialization

Citations

This map shows the geographic impact of Meredith C. Henderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meredith C. Henderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meredith C. Henderson more than expected).

Fields of papers citing papers by Meredith C. Henderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meredith C. Henderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meredith C. Henderson. The network helps show where Meredith C. Henderson may publish in the future.

Co-authorship network of co-authors of Meredith C. Henderson

This figure shows the co-authorship network connecting the top 25 collaborators of Meredith C. Henderson. A scholar is included among the top collaborators of Meredith C. Henderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meredith C. Henderson. Meredith C. Henderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women over age 50 with BI-RADS 3, 4, or 5 Assessment 2018 ·Clinical Cancer Research ·Meredith C. Henderson, Michael Silver, (unknown), (unknown), (unknown), David E. Reese, Ana P. Lourenço, Joshua LaBaer, Karen S. Anderson, (unknown), (unknown), Nitin Rohatgi, Haythem Ali, (unknown), Donald W. Northfelt, Karthik Ghosh, Stephen R. Grobmyer, (unknown), Judith K. Wolf	17
2	A Combinatorial Proteomic Biomarker Assay to Detect Ovarian Cancer in Women 2018 ·SHILAP Revista de lepidopterología ·Meredith C. Henderson, Michael Silver, Sherri Borman, (unknown), (unknown), (unknown), David E. Reese, Judith K. Wolf	1
3	A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years 2017 ·Clinical Breast Cancer ·Ana P. Lourenço, (unknown), Meredith C. Henderson, Michael Silver, (unknown), (unknown), Kelly J. Gordon, Sherri Borman, (unknown), (unknown), Wendy Smith, (unknown), (unknown), Nitin Rohatgi, Rebecca Yang, (unknown), (unknown), Michael Morris, (unknown), David E. Reese	21
4	Breast density does not impact the ability of Videssa® Breast to detect breast cancer in women under age 50 2017 ·PLoS ONE ·David E. Reese, Meredith C. Henderson, Michael Silver, (unknown), (unknown), (unknown), Judith K. Wolf	6
5	Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer 2016 ·PLoS ONE ·Meredith C. Henderson, Alan B. Hollingsworth, Kelly J. Gordon, Michael Silver, (unknown), (unknown), David E. Reese	25
6	High-Throughput RNAi Screening for the Identification of Novel Targets 2013 ·Methods in molecular biology ·Meredith C. Henderson, David O. Azorsa	8
7	dtectDx Breast: A serum biomarker test for breast cancer detection used in conjunction with traditional mammography screening. 2013 ·Journal of Clinical Oncology ·Meredith C. Henderson, (unknown), Sherri Borman, (unknown), (unknown), David E. Reese	1
8	The Genomic and Proteomic Content of Cancer Cell-Derived Exosomes 2012 ·SHILAP Revista de lepidopterología ·Meredith C. Henderson, David O. Azorsa	153
9	High-throughput RNAi Screening Identifies a Role for TNK1 in Growth and Survival of Pancreatic Cancer Cells 2011 ·Molecular Cancer Research ·Meredith C. Henderson, (unknown), Shilpi Arora, Ashish Choudhary, Jeffrey M. Trent, Daniel D. Von Hoff, Spyro Mousses, David O. Azorsa	26
10	NCI60 Cancer Cell Line Panel Data and RNAi Analysis Help Identify EAF2 as a Modulator of Simvastatin and Lovastatin Response in HCT-116 Cells 2011 ·PLoS ONE ·Sevtap Savas, David O. Azorsa, Hamdi Jarjanazi, Irada Ibrahim-zada, (unknown), Shilpi Arora, Meredith C. Henderson, Yun‐Hee Choi, Laurent Briollais, Hilmi Özçelik, Şükrü Tüzmen	14
11	The impact of bilateral therapy on upper limb function after chronic stroke: a systematic review 2010 ·Disability and Rehabilitation ·(unknown), (unknown), (unknown), Meredith C. Henderson, Leigh Hale	46
12	UA62784, a novel inhibitor of centromere protein E kinesin-like protein 2009 ·Molecular Cancer Therapeutics ·Meredith C. Henderson, (unknown), Hong Wang, Haiyong Han, Laurence H. Hurley, Gary A. Flynn, Robert T. Dorr, Daniel D. Von Hoff	42
13	Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer 2009 ·Journal of Translational Medicine ·David O. Azorsa, (unknown), Gargi D. Basu, Ashish Choudhary, Shilpi Arora, Kristen Bisanz, Jeffrey Kiefer, Meredith C. Henderson, Jeffrey M. Trent, Daniel D. Von Hoff, Spyro Mousses	82
14	Characterization of Novel Diaryl Oxazole-Based Compounds as Potential Agents to Treat Pancreatic Cancer 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Arthur Y. Shaw, Meredith C. Henderson, Gary A. Flynn, Betty K. Samulitis, Haiyong Han, (unknown), H.‐H. Sherry Chow, Laurence H. Hurley, Robert T. Dorr	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact